In order to implement the spirit of the 20th National Congress of the Communist Party of China and give full play to the role of the special consultative body of the CPPCC, on the morning of December 14, the series of activities of the Nanshan District CPPCC Federation of Industry and Commerce Sector Committee Workstation Reading and Sharing Meeting and the Nanshan District Drug Clinical Trial Base (GCP) Alliance Symposium were successfully held in Nanshan Medical Device Industrial Park. The event was hosted by the Nanshan District CPPCC Federation of Industry and Commerce Sector Member Workstation, supported and participated by the Medical and Health Sector Member Workstation, undertaken by Shenzhen Baiying High-end Medical Equipment Scientific and Technological Achievement Transformation Center, and attended by Huang Xianfeng, Vice Chairman of Nanshan District CPPCC, and more than 20 members of the CPPCC Workstation.
At the beginning of the event, after arriving at Nanshan Medical Device Industrial Park, the participants first visited the resident enterprise in the park - Shenzhen Qianhai Chuangsheng Medical Technology Co., Ltd. As a wholly-owned subsidiary of Zhongke Gene Biotechnology (Jiangsu) Co., Ltd., Qianhai Chuangsheng cooperates with a number of hospitals and medical institutions, with "genetic testing + cell CAR-T therapy + stem cell health application services" as its main business, and is a practitioner of precision medicine and stem cell industry vigorously advocated by the country.
In addition to visiting the representative companies of the precision medicine and stem cell industry in the park, Tang Zhixiong, technical director of Shenzhen Qianhai Chuangsheng Medical Technology Co., Ltd., was specially invited as a keynote speaker to bring a keynote speech entitled "Precision Medicine and Cell Therapy Industry Report", which mainly includes the development of tumor genetic testing, the important role of genetic testing in the whole process of precision diagnosis and treatment of tumors, the future of tumor genetic testing, and the current challenges and opportunities of tumor treatment.
In the book donation session, Huang Xianfeng, vice chairman of the CPPCC Nanshan District, presented the book "Transformation - How Good Technology Becomes Good Business" to the guests, hoping to bring inspiration to the guests in terms of "from plan to implementation" and "from technology research and development to marketization".
At the symposium of the Nanshan District Drug Clinical Trial Base (GCP) Alliance, Wu Chen, representative of the Drug Clinical Trial Base (GCP) Alliance and deputy director of the Nanshan District Health Bureau, made an opening speech, she proposed that the biomedical industry in Nanshan District has not yet fully formed a joint force in terms of incubation and achievement transformation, such as scientific research institutes, medical institutions, and enterprises have fewer communication channels and are not closely connected, and hope to build an exchange platform to further strengthen industrial cooperation through the formation of GCP Alliance.
Subsequently, representatives of hospitals and enterprises delivered speeches one after another, giving full play to their respective professional and experience advantages, based on the current situation of the biomedical industry, focusing on the "Nanshan District Biomedicine (Cell and Gene Direction) Achievement Transformation" related topics to discuss and share, collide views, and speak freely.
Sun Peng, vice president of Shenzhen Nanshan District Maternal and Child Health Hospital, said that most clinical trials are still facing problems in terms of insurance and legal risks, as well as restrictions on relevant laws and regulations. Li Hao, co-founder and CIO of iCarbon, hopes to strengthen cooperation with medical institutions in Nanshan District in the future, starting from scientific research, and actively promoting the establishment of joint laboratories and GCP alliances. Zhou Chen, executive director of Baiying (Shenzhen) Group Co., Ltd., suggested that enterprises will indeed encounter various problems in the process of incubation and transformation, taking GCP as an example, huge investment is a heavy burden for start-ups, and hopes that Nanshan District can establish a professional transformation agency in the future to guide enterprises and help them develop. Wu Zhengyu, founder and CEO of Nuokang Medical, hopes that more clinical trials will be implemented in Nanshan District in the future to promote the development of the industry.
Realize industrial agglomeration, and call on more alliances and experts to participate in the GCP alliance, communicate with each other, and make good use of the alliance to promote the overall improvement of medical level and scientific research capabilities.
Finally, Huang Xianfeng, vice chairman of the CPPCC Nanshan District, summarized the symposium, analyzed the current situation of the biomedical and medical device industries in Nanshan District from various aspects such as financial payment methods, incentive and safeguard measures, platform cooperation models, and regional industrial policies, and put forward suggestions for the industrial development of Nanshan District.
In the process of promoting the transformation of achievements, the Nanshan District CPPCC Federation of Industry and Commerce Sector Member Workstation has played an important role and provided indispensable services and resources. By carrying out a series of characteristic activities such as "enterprise visits", "keynote speeches" and "special seminars", we will further give full play to the organizational and synergistic advantages of the Nanshan District CPPCC Federation of Industry and Commerce member workstations, rely on the platform of Baiying Group Nanshan Medical Device Industrial Park, listen to the demands of all parties in the field of biomedical achievement transformation, and implement the "five major actions" of the CPPCC District to promote the high-quality development of Nanshan, and contribute wisdom and strength to the high-quality development of Nanshan District.